XML 42 R23.htm IDEA: XBRL DOCUMENT v3.24.3

Net Loss Per Share

8 Months Ended

Sep. 30, 2024

Net Loss Per Share [Abstract]

Net Loss per Share

12. Net Loss per Share

Basic and diluted net loss per share attributable to stockholders were calculated as follows (in thousands, except share and per share data): 

		Three Months Ended September 30, 2024												Period from February 6, 2024 (Inception) to September 30, 2024
		Loss Allocation				Weighted Average Shares Outstanding				Loss Per Share – Basic and Diluted				Loss Allocation				Weighted Average Shares Outstanding				Loss Per Share – Basic and Diluted
Common Stock		$	(21,936	)			15,013,655			$	(1.46	)		$	(47,192	)			7,765,381			$	(6.08	)
Company Series A Preferred Stock(1)			(697	)			477			$	(1,460.62	)			(1,121	)			184			$	(6,077.13	)
Company Series B Preferred Stock(2)			(5,990	)			49,191			$	(121.77	)			(9,630	)			19,015			$	(506.44	)
Net loss		$	(28,623	)										$	(57,943	)

(1) The weighted-average number of shares of as-converted Company Series A Preferred Stock used in the loss allocation was 477,196 and 184,462 for the three months ended September 30, 2024 and for the period from February 6, 2024 (inception) to September 30, 2024, respectively.

(2) The weighted-average number of shares of as-converted Company Series B Preferred Stock used in the loss allocation was 4,099,227 and 1,584,575 for the three months ended September 30, 2024 and for the period from February 6, 2024 (inception) to September 30, 2024, respectively.

For the computation of basic net loss per share attributable to stockholders, the amount of weighted-average shares outstanding excludes all shares of unvested restricted common stock as such shares are not considered outstanding for accounting purposes until vested. The amount of weighted-average shares outstanding includes the pre-funded warrants as the exercise price is negligible and these warrants are fully vested and exercisable.

The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to stockholders for the periods presented because including them would have had an anti-dilutive effect were as follows: 

		Three Months Ended September 30, 2024				Period from February 6, 2024 (Inception) to September 30, 2024
Outstanding employee warrants to purchase common stock			3,054,358				3,054,358
Outstanding unvested restricted stock awards			2,207,553				2,207,553
Outstanding and issued common stock options			1,287,760				1,287,760
Total			6,549,671				6,549,671

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/260/tableOfContent

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-3

+ Details

Name:	us-gaap_EarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration